New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung ...

The Phase 2a trial enrolled 35 IPF patients randomized in a 2:1 ratio to receive either GRI-0621 or placebo once daily for 12 weeks. A sub-study examined immune cells in bronchoalveolar lavage fluid ...

White list for cross-border data transfers is being established to enhance transparency and pave the way for deeper ...

On January 8, 2026, GRI Bio reported additional positive immune profiling data from its Phase 2a clinical trial of GRI-0621 in idiopathic pulmonary fibrosis, showing inhibition of invariant NKT cells ...

Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering ...

Cryopreservation Freezer Market Size The global Cryopreservation Freezer Market was valued at USD 568 Million in the year ...

"CGIE (TM) is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory--the ...

Illumina has unveiled a database of genomic alterations, called the Billion Cell Atlas, that can be used to identify and ...

IndyGeneUS Bio today announced the filing of a patent application covering its Clinico-Genomic Insight Engine™ ...

H aving kids is costly. Not just financially, but biologically, too. At least in theory. Evolutionary biologists propose that ...